Clinical Trials Logo

Colorectal Cancer Stage IV clinical trials

View clinical trials related to Colorectal Cancer Stage IV.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04157322 Active, not recruiting - Clinical trials for Colorectal Cancer Metastatic

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

Start date: August 26, 2019
Phase:
Study type: Observational

Patients with peritoneal metastasis of colorectal or high grade appendiceal origin who are candidates for cytoreductive surgery with HIPEC (hyperthermic intraperitoneal chemotherapy) will be enrolled in this study. Blood collection for measurements of plasma cell-free DNA hydroxymethylation signatures will be performed at different time points, before and after surgery, in order to determine if plasma hydroxymethylation signatures are more sensitive than conventional tumor markers in identifying clinically detectable recurrence at 1 year after surgery.

NCT ID: NCT03986541 Active, not recruiting - Clinical trials for Colorectal Cancer Stage IV

AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer

Start date: September 23, 2019
Phase:
Study type: Observational

Observational study investigating the relationship between tumour amphiregulin, epiregulin and epithelial growth factor receptor expression and response to anti-EGFR agents in advanced colorectal cancer.

NCT ID: NCT02618850 Active, not recruiting - Clinical trials for Colorectal Cancer Stage IV

PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment

PETRA2 - CRC
Start date: April 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to test whether an early metabolic response, measured by PET/CT scan after the first cycle of chemotherapy, is able to predict which patients with advanced CRC have a better prognosis.